Xploro provides age-appropriate, disease-agnostic, clinically-validated patient education for young patients using games, augmented reality, a chatbot, and customizable content across healthcare disciplines. Its platform is available in multiple languages and is used in diverse healthcare settings; the company collaborates with World Child Cancer and partners with Cincinnati Children’s Hospital, University Hospitals Cleveland, and several NHS Trusts. Founded in the UK in 2019, Xploro relocated to Cleveland, Ohio in 2022 and is led by Co‑Founder & CEO Dominic Raban. The company initially focused on pediatric patients aged 7–15 and plans to expand to all ages and conditions, targeting the $12.53 billion global pediatric healthcare market and entering the adult healthcare sector by 2025. Xploro raised $1.7M in Seed funding to support growth initiatives, including expanding into new treatment areas, enhancing sales and customer success functions, and broadening condition coverage. Management says the raise is intended to secure runway through 2025 and to enable involvement of third-party content creators. Xploro is an award-winning, clinically verified mobile health application that leverages augmented reality, gameplay, and artificial intelligence to explain medical procedures and information to children in accessible language. The platform aims to reduce procedural anxiety, improve child health literacy, and shorten or reduce repeat procedures by preparing young patients for treatment. Xploro reports one of the highest ORCHA scores, reflecting compliance and best-practice in digital health. The company was founded in 2019 and positions its product to empower patients to better self-manage their healthcare. Management says continued development and innovation of the platform will allow Xploro to reach more families and support children during serious illness. The app’s combination of AR, AI, and games is presented as a way to enhance clinical outcomes by reducing fear and improving awareness of treatment.

Total raised

$2M

Funding rounds

2

Latest round

Seed

Latest activity

Dec 2023